NCT01789255 · OUTCOME
The Percentage of Patients With Relapse at 1 Year
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of patients
- Interval / dispersion
- Not reported
- Time frame
- Up to 1 year
Groups in this outcome
Supportive Care (Vorinostat, Tacrolimus, Methotrexate)
Patients receive vorinostat PO BID on days -10 to 100. Beginning on day -3, patients receive tacrolimus IV continuously or PO BID (or cyclosporine IV continuously or PO in patients unable to tolerate tacrolimus) with taper on days 100-180. Patients also receive methotrexate IV QD on days 1, 3, 6, and 11.
| Group | Source count |
|---|---|
| Supportive Care (Vorinostat, Tacrolimus, Methotrexate) | 12 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Supportive Care (Vorinostat, Tacrolimus, Methotrexate) | 19 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 19
- denoms
- counts
- group Id
- OG000
- value
- 12
- units
- Participants
- groups
- description
- Patients receive vorinostat PO BID on days -10 to 100. Beginning on day -3, patients receive tacrolimus IV continuously or PO BID (or cyclosporine IV continuously or PO in patients unable to tolerate tacrolimus) with taper on days 100-180. Patients also receive methotrexate IV QD on days 1, 3, 6, and 11.
- id
- OG000
- title
- Supportive Care (Vorinostat, Tacrolimus, Methotrexate)
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- Up to 1 year
- title
- The Percentage of Patients With Relapse at 1 Year
- type
- SECONDARY
- unit Of Measure
- percentage of patients
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle